98 related articles for article (PubMed ID: 14582303)
1. [Free dispensing of antiretroviral treatments in Africa].
Taverne B
Bull Soc Pathol Exot; 2003 Aug; 96(3):241-4. PubMed ID: 14582303
[TBL] [Abstract][Full Text] [Related]
2. [Impact of access to antiretroviral therapy in Côte d'Ivoire].
Eholié SP; Tanon KA; Folquet-Amorissani M; Ouattara I; Aba YT; Traoré-Ettiegne V; Kakou AR; Aoussi E; Anglaret X; Bissagnéné E
Med Trop (Mars); 2009 Oct; 69(5):520-4. PubMed ID: 20025190
[TBL] [Abstract][Full Text] [Related]
3. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment.
Nguyen VK; Ako CY; Niamba P; Sylla A; Tiendrébéogo I
AIDS; 2007 Oct; 21 Suppl 5():S31-5. PubMed ID: 18090265
[TBL] [Abstract][Full Text] [Related]
4. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
Beaulière A; Le Maux A; Trehin C; Perez F
Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
[TBL] [Abstract][Full Text] [Related]
5. [Poor access to antiretroviral treatment in French-speaking Africa: situation in 2004].
Boisseau C; Degui H; Bruneton C; Rey JL
Med Trop (Mars); 2006 Dec; 66(6):589-92. PubMed ID: 17286029
[TBL] [Abstract][Full Text] [Related]
6. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria.
Uzochukwu BS; Onwujekwe OE; Onoka AC; Okoli C; Uguru NP; Chukwuogo OI
Health Policy Plan; 2009 May; 24(3):189-96. PubMed ID: 19276155
[TBL] [Abstract][Full Text] [Related]
7. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.
Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro J; Diby CJ; Toni T; Dohoun L; Rouzioux C; Bissagnene E; Salamon R; Anglaret X;
J Infect Dis; 2009 Jan; 199(1):66-76. PubMed ID: 18986246
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
Katzenstein D; Laga M; Moatti JP
AIDS; 2003 Jul; 17 Suppl 3():S1-4. PubMed ID: 14565603
[No Abstract] [Full Text] [Related]
9. An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'Ivoire.
Diaby V; Lachaine J
Appl Health Econ Health Policy; 2011 Nov; 9(6):389-402. PubMed ID: 22017499
[TBL] [Abstract][Full Text] [Related]
10. Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria.
Onwujekwe O; Dike N; Chukwuka C; Uzochukwu B; Onyedum C; Onoka C; Ichoku H
Health Policy; 2009 May; 90(2-3):223-9. PubMed ID: 19036466
[TBL] [Abstract][Full Text] [Related]
11. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
[TBL] [Abstract][Full Text] [Related]
12. How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa.
Fredlund VG; Nash J
J Infect Dis; 2007 Dec; 196 Suppl 3():S469-73. PubMed ID: 18181696
[TBL] [Abstract][Full Text] [Related]
13. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
14. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M; Koffi CK
AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
[TBL] [Abstract][Full Text] [Related]
15. Combining prevention, treatment and care: lessons from South Africa.
Achmat Z; Simcock J
AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
[TBL] [Abstract][Full Text] [Related]
16. The obligation to provide antiretroviral treatment in HIV prevention trials.
Lo B; Padian N; Barnes M
AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
[TBL] [Abstract][Full Text] [Related]
17. Community-based health insurance and access to maternal health services: evidence from three West African countries.
Smith KV; Sulzbach S
Soc Sci Med; 2008 Jun; 66(12):2460-73. PubMed ID: 18362047
[TBL] [Abstract][Full Text] [Related]
18. [Observance of antiretroviral treatments: African specificities].
Eholié SP; N'dour CT; Cissé M; Bissagnéné E; Girard PM
Med Mal Infect; 2006 Sep; 36(9):443-8. PubMed ID: 17027212
[TBL] [Abstract][Full Text] [Related]
19. Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire.
Tehe A; Maurice C; Hanson DL; Borget MY; Abiola N; Maran M; Yavo D; Tomasik Z; Böni J; Schüpbach J; Nkengasong JN
J Clin Virol; 2006 Nov; 37(3):199-205. PubMed ID: 16973409
[TBL] [Abstract][Full Text] [Related]
20. Migrants' access to antiretroviral therapy in Thailand.
Saether ST; Chawphrae U; Zaw MM; Keizer C; Wolffers I
Trop Med Int Health; 2007 Aug; 12(8):999-1008. PubMed ID: 17697095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
